Role of vascular mitogens in subarachnoid hemorrhage-associated cerebral vasculopathy

Neurocritical Care

Volumn 5, Issue 3, 2006, Pages 215-221

  Miller, Cheryl A ^a   Lombard, Frederick W ^b   Wu, Ching Tang ^c   Hubbard, Cory J ^d   Silbajoris, Lydia ^a   Borel, Cecil O ^b   Niklason, Laura E ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^d Duke University Medical Center ^*

Author keywords

Cerebral arteries; Cerebral vasculopathy; Delayed cerebral ischemia; Intracranial; Platelet derived growth factor; Subarachnoid hemorrhage; Vascular endothelial growth factor; Vasospasm

Indexed keywords

CYCLINE; MITOGENIC AGENT; PLATELET DERIVED GROWTH FACTOR AB; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTERY OCCLUSION; ARTICLE; BASILAR ARTERY; BLOOD CLOTTING; BRAIN ANGIOGRAPHY; BRAIN TISSUE; CELL PROLIFERATION; CEREBROSPINAL FLUID; CEREBROVASCULAR DISEASE; CISTERNA MAGNA; CONTROLLED STUDY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RABBIT; SIMULATION; STAINING; SUBARACHNOID HEMORRHAGE; VASCULAR ENDOTHELIUM;

ANIMALS; BASILAR ARTERY; BRAIN ISCHEMIA; CELL DIVISION; CEREBRAL ANGIOGRAPHY; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; MALE; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; RABBITS; SUBARACHNOID HEMORRHAGE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR RESISTANCE; VASOSPASM, INTRACRANIAL;

EID: 33846970941     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1385/NCC:5:3:215     Document Type: Article

References (24)

1. Macdonald R. Pathophysiology and molecular genetics of vasospasm. Acta Neurochir Suppl 2001;77:7-11.
2. Rabinstein A, Pichelmann M, Friedman J, et al. Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: a comparison between surgical repair and endovascular coil occlusion. J Neurosurg 2003;98:319-325.
3. Mayberg MR. Cerebral vasospasm. Neurosurg Clin N Am 1998;9:615-627.
4. Dorsch N. Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr Opin Crit Care 2002;8:128-133.
5. Mayberg M, Okada T, Bark D. Morphologic changes in cerebral arteries after subarachnoid hemorrhage. Neurosurg Clin N Am 1990;1:417-429.
6. Graves E. Detailed diagnoses and procedures. National Hospital Discharge Survey, 1990. 1992;Vital Health Statistics 13:113-225.
7. Raines EW, Ross R. Platelet-derived growth factor in vivo. In: Westermark B, Sorg C, ed. Biology of platelet-derived growth factor. Basel: Karger, 1993.
8. Plate KH, Warnke PC. Vascular endothelial growth factor. J Neurooncol 1997;35:365-372.
9. Borel C, McKee A, Parra A, et al. A possible role for vascular cell proliferation in cerebral vasospasm following subarachnoid hemorrhage. Stroke 2003;34:427-433.
10. Pollay M, Davson H. The passage of certain substances out of the cerebrosphinal fluid. Brain 1963;86:137-150.
11. Zhang A. Broad-spectrum and selective serine protease inhibitors prevent expression of platelet-derived growth factor-bb and cerebral vasospasm after subarachnoid hemorrhage. Stroke 2001;32:1665-1672.
12. Masson PJ. J Technol Methods 1929;12:75
13. Lindman HR, ed. Analysis of variance in experimental design. New York: Springer-Verlag, 1992.
14. Montgomery DC, ed. Design and analysis of experiments. New York: John Wiley & Sons Inc, 1997.
15. Vorkapic P, Bevan R, Bevan J. Longitudinal time course of reversible and irreversible components of chronic cerebrovasospasm of the rabbit basilar artery. J Neurosurg 1991;74:951-955.
16. Salgado R, Benoy I, Bogers J, et al. Platelets and vascular endothelial growth factor (VEGF): a morphological and functional study. Angiogenesis 2001;4:37-43.
17. Schwartz SM, deBlois D, O'Brien ER. The intima. Soil for atherosclerosis and restenosis. Circ Res 1995;77:445-465.
18. Takenaka K, Goto Y, Kassell N, Lee K. Modification of vascular smooth muscle proteins in rabbit basilar artery after subarachnoid hemorrhage. In: Findlay J, ed. Cerebral vasospasm. Amsterdam: Elsevier, 1993, pp. 93-96.
19. Vorkapic P, Bevan R, Bevan J. Pharmacologic irreversible narrowing in chronic cerebrovasospasm in rabbits is associated with functional damage. Stroke 1990;21:1478-1484.
20. Megyesi J, Vollrath B, Cook D, Findlay J. In vivo animal models of cerebral vasospasm: a review. Neurosurg 2000;46:448-461.
21. Lin CL, Jeng AY, Howng SL, Kwan AL. Endothelin and subarachnoid hemorrhage-induced cerebral vasospasm: pathogenesis and treatment. Curr Med Chem 2004;11:1779-1791.
22. Faraci F, Heistad D. Regulation of cerebral circulation: role of endothelium and potassium channels. Physiol Rev 1998;78:53-97.
23. Takenaka K, Kishino J, Yamada H, et al. DNA synthesis and intracellular calcium elevation in porcine cerebral arterial smooth muscle cells by cerebrospinal fluid from patients with subarachnoid haemorrhage. Neurol 1992;14:330-334.
24. Smith R, Clower B, Grotendorst G, Yabuno N, Cruse J. Arterial wall changes in early human vasospasm. Neurosurg 1985;16:171-176.